1. Home
  2. ORIC vs BAND Comparison

ORIC vs BAND Comparison

Compare ORIC & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • BAND
  • Stock Information
  • Founded
  • ORIC 2014
  • BAND 2000
  • Country
  • ORIC United States
  • BAND United States
  • Employees
  • ORIC N/A
  • BAND N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • BAND Computer Software: Prepackaged Software
  • Sector
  • ORIC Health Care
  • BAND Technology
  • Exchange
  • ORIC Nasdaq
  • BAND Nasdaq
  • Market Cap
  • ORIC 1.1B
  • BAND 473.2M
  • IPO Year
  • ORIC 2020
  • BAND 2017
  • Fundamental
  • Price
  • ORIC $12.66
  • BAND $16.22
  • Analyst Decision
  • ORIC Strong Buy
  • BAND Buy
  • Analyst Count
  • ORIC 8
  • BAND 6
  • Target Price
  • ORIC $16.57
  • BAND $20.80
  • AVG Volume (30 Days)
  • ORIC 1.5M
  • BAND 215.2K
  • Earning Date
  • ORIC 11-11-2025
  • BAND 10-30-2025
  • Dividend Yield
  • ORIC N/A
  • BAND N/A
  • EPS Growth
  • ORIC N/A
  • BAND N/A
  • EPS
  • ORIC N/A
  • BAND N/A
  • Revenue
  • ORIC N/A
  • BAND $758,106,000.00
  • Revenue This Year
  • ORIC N/A
  • BAND $2.47
  • Revenue Next Year
  • ORIC N/A
  • BAND $13.92
  • P/E Ratio
  • ORIC N/A
  • BAND N/A
  • Revenue Growth
  • ORIC N/A
  • BAND 14.51
  • 52 Week Low
  • ORIC $3.90
  • BAND $11.33
  • 52 Week High
  • ORIC $14.93
  • BAND $23.00
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 52.55
  • BAND 52.80
  • Support Level
  • ORIC $13.15
  • BAND $15.13
  • Resistance Level
  • ORIC $14.17
  • BAND $15.74
  • Average True Range (ATR)
  • ORIC 0.85
  • BAND 0.59
  • MACD
  • ORIC -0.16
  • BAND -0.05
  • Stochastic Oscillator
  • ORIC 40.20
  • BAND 77.27

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

Share on Social Networks: